Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transgelin is a novel marker of smooth muscle differentiation that improves diagnostic accuracy of leiomyosarcomas: a comparative immunohistochemical reappraisal of myogenic markers in 900 soft tissue tumors.
Robin YM, Penel N, Pérot G, Neuville A, Vélasco V, Ranchère-Vince D, Terrier P, Coindre JM. Robin YM, et al. Among authors: penel n. Mod Pathol. 2013 Apr;26(4):502-10. doi: 10.1038/modpathol.2012.192. Epub 2012 Nov 23. Mod Pathol. 2013. PMID: 23174934 Free article.
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis.
Bay JO, Ray-Coquard I, Fayette J, Leyvraz S, Cherix S, Piperno-Neumann S, Chevreau C, Isambert N, Brain E, Emile G, Le Cesne A, Cioffi A, Kwiatkowski F, Coindre JM, Bui NB, Peyrade F, Penel N, Blay JY; Groupe Sarcome Français. Bay JO, et al. Among authors: penel n. Int J Cancer. 2006 Aug 1;119(3):706-11. doi: 10.1002/ijc.21867. Int J Cancer. 2006. PMID: 16496406 Free article. Clinical Trial.
Imaging of the most frequent superficial soft-tissue sarcomas.
Morel M, Taïeb S, Penel N, Mortier L, Vanseymortier L, Robin YM, Gosset P, Cotten A, Ceugnart L. Morel M, et al. Among authors: penel n. Skeletal Radiol. 2011 Mar;40(3):271-84. doi: 10.1007/s00256-009-0855-y. Epub 2010 Jan 13. Skeletal Radiol. 2011. PMID: 20069421 Review.
Angiosarcoma: state of the art and perspectives.
Penel N, Marréaud S, Robin YM, Hohenberger P. Penel N, et al. Crit Rev Oncol Hematol. 2011 Nov;80(2):257-63. doi: 10.1016/j.critrevonc.2010.10.007. Epub 2010 Nov 4. Crit Rev Oncol Hematol. 2011. PMID: 21055965 Review.
Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).
Ray-Coquard I, Italiano A, Bompas E, Le Cesne A, Robin YM, Chevreau C, Bay JO, Bousquet G, Piperno-Neumann S, Isambert N, Lemaitre L, Fournier C, Gauthier E, Collard O, Cupissol D, Clisant S, Blay JY, Penel N; French Sarcoma Group (GSF/GETO). Ray-Coquard I, et al. Among authors: penel n. Oncologist. 2012;17(2):260-6. doi: 10.1634/theoncologist.2011-0237. Epub 2012 Jan 27. Oncologist. 2012. PMID: 22285963 Free PMC article. Clinical Trial.
Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF/GETO).
Lindet C, Neuville A, Penel N, Lae M, Michels JJ, Trassard M, Terrier P, Birtwisle-Peyrottes I, Valo I, Collin F, Chateau MC, Robin YM, Coindre JM. Lindet C, et al. Among authors: penel n. Eur J Cancer. 2013 Jan;49(2):369-76. doi: 10.1016/j.ejca.2012.08.016. Epub 2012 Sep 8. Eur J Cancer. 2013. PMID: 22967726 Free article.
440 results